APA
Agilli M., Aydin F. N., . (20160404). Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Chicago
Agilli Mehmet, Aydin Fevzi Nuri, . 20160404. Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Harvard
Agilli M., Aydin F. N., . (20160404). Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
MLA
Agilli Mehmet, Aydin Fevzi Nuri, . Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 20160404.